Mustang Bio
MBIO · NASDAQ
$0.3795+$0.0065 (+1.74%)TodayMarket closed ·
Prev close $0.373
EPS: actual vs estimate
Beat the estimate in 5 of the last 8 quarters, by 31.7% on average
Reported EPS
Estimated EPS
| Quarter | Estimate | Reported | Surprise |
|---|---|---|---|
| Q4 FY24 | -$8.16 | -$37.95 | −365.1% |
| Q3 FY24 | -$6.63 | -$2.00 | +69.8% |
| Q4 FY23 | -$67.83 | -$43.00 | +36.6% |
| Q3 FY23 | -$65.03 | -$70.00 | −7.7% |
| Q2 FY23 | -$92.18 | -$100.00 | −8.5% |
| Q1 FY23 | -$153.51 | -$103.00 | +32.9% |
| Q4 FY22 | -$147.26 | -$135.00 | +8.3% |
| Q3 FY22 | -$151.09 | -$135.00 | +10.6% |
Earnings calls
- B. Riley Securities' 3rd Annual Oncology Conference
- Special Call - Mustang Bio, Inc.
- Special Call - Mustang Bio, Inc.
- Special Call - Mustang Bio, Inc.
- Shareholder/Analyst Call - Mustang Bio, Inc.
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.